2020 Volume 46 Issue 12 Pages 722-731
Novel coronavirus disease 2019 (COVID-19) caused a worldwide pandemic, requiring medical institutions to take measures against nosocomial infections and to establish a medical care framework for COVID-19 patients. Hospital pharmacists have taken measures to provide medical support to COVID-19. Through preparation for use of unapproved or off-label COVID-19 therapeutic agents, pharmacist work conducted in the ward by a delegated full-time pharmacist, and drug arrangement for the fever clinic, we evaluated infection control measures and evaluated and monitored the safety and efficacy of COVID-19 therapeutic agents. We believe that the medical support provided reduces the burden on medical staff, and COVID-19 patients were able to receive treatment with peace of mind by deepening their understanding of medication for COVID-19. In preparation for the re-emergence of COVID-19, it was considered important for hospital pharmacists to determine issues of medical support for patients by practical application and to take measures.
